PURPOSE: Accurate staging of early non-small cell lung cancer is fundamental for selecting the best treatment. The aim of this study was to identify risk factors for nodal upstaging after video-assisted thoracoscopic lobectomy for clinical T1-3N0 tumors. METHODS: From 2014 to 2017, 3276 thoracoscopic lobectomies were recorded in the prospective database "Italian VATS Group". Linear and multiple logistic regression models were adapted to identify independent predictors of nodal upstaging and factors associated with progression in postoperative N status. RESULTS: Nodal upstaging was found in 417 cases (12.7%), including 206 cases (6.2%) of N1-positive nodes, 81 cases of N2 nodes (2.4%), and 130 cases (4%) of involvement of both N1 + N2 nodes. A total of 241 (7.3%) patients had single-station nodal involvement, whereas 176 (5.3%) had multiple-station involvement. In the final regression model, the tumor grade, histology, pathologic T status, and > 12 resected nodes were independent predictors of nodal upstaging. CONCLUSIONS: The number of resected lymph nodes seems to predict nodal upstaging better than the type of intraoperative lymph node management. Other preoperative risk factors correspond to those for which the current guidelines of the European Society of Thoracic Surgery recommend more extensive preoperative mediastinal staging.
Predictors of nodal upstaging in patients with cT1‑3N0 non‑small cell lung cancer (NSCLC): results from the Italian VATS Group Registry / Giuseppe, Marulli; Eleonora, Faccioli; ·marco, Mammana; Samuele, Nicotra; Giovanni, Comacchio; Enrico, Verderi; Angela De, Palma; Federico, Rea; Stefani, Alessandro. - In: SURGERY TODAY. - ISSN 0941-1291. - 50:7(2020), pp. 711-718. [10.1007/s00595-019-01939-x]
Predictors of nodal upstaging in patients with cT1‑3N0 non‑small cell lung cancer (NSCLC): results from the Italian VATS Group Registry
Stefani AlessandroMembro del Collaboration Group
2020
Abstract
PURPOSE: Accurate staging of early non-small cell lung cancer is fundamental for selecting the best treatment. The aim of this study was to identify risk factors for nodal upstaging after video-assisted thoracoscopic lobectomy for clinical T1-3N0 tumors. METHODS: From 2014 to 2017, 3276 thoracoscopic lobectomies were recorded in the prospective database "Italian VATS Group". Linear and multiple logistic regression models were adapted to identify independent predictors of nodal upstaging and factors associated with progression in postoperative N status. RESULTS: Nodal upstaging was found in 417 cases (12.7%), including 206 cases (6.2%) of N1-positive nodes, 81 cases of N2 nodes (2.4%), and 130 cases (4%) of involvement of both N1 + N2 nodes. A total of 241 (7.3%) patients had single-station nodal involvement, whereas 176 (5.3%) had multiple-station involvement. In the final regression model, the tumor grade, histology, pathologic T status, and > 12 resected nodes were independent predictors of nodal upstaging. CONCLUSIONS: The number of resected lymph nodes seems to predict nodal upstaging better than the type of intraoperative lymph node management. Other preoperative risk factors correspond to those for which the current guidelines of the European Society of Thoracic Surgery recommend more extensive preoperative mediastinal staging.File | Dimensione | Formato | |
---|---|---|---|
Predictors of nodal upstaging in patients with cT1-3N0 NSCLC (correction).pdf
Accesso riservato
Descrizione: correzione all'articolo principale
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
344.29 kB
Formato
Adobe PDF
|
344.29 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Predictors of nodal upstaging in patients with cT1-3N0 NSCLC (original article).pdf
Accesso riservato
Descrizione: articolo originale senza correzione
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
662.67 kB
Formato
Adobe PDF
|
662.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris